contraindication to glp 1 GLP‑1 Drugs: Obesity & Diabetes Treatment Fight GLP-1 drugs and aspiration risk

Focusing on the molecular systems behind the dopaminergic modulation, it was shown that GLP-1R signaling in the VTA alters presynaptic modulation of glutamatergic excitation of dopamine neurons via AMPA/kainate but not NMDA receptors

Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) Study

Stacking protocols using multiple peptides benefit from staggered reconstitution

She also became by far the most prominent athlete to compete at the highest level of their sport having taken GLP-1 drugs, which anti-doping authorities have been monitoring since 2024

2014 Dec;11(6):705-1

Its likely to be due to several factors